...replaces Theresa Deisher, AVM’s founder, who is chairman, president and CSO. Cox was previously CEO of Protein Sciences Corp....

...an approved quadrivalent seasonal flu vaccine developed with the technology, via its 2017 acquisition of Protein Sciences Corp....
...to test a preclinical severe acute respiratory syndrome (SARS) vaccine that had been developed by Protein Sciences...

...Flublok, received FDA approval in 2013. The Sanofi Pasteur division of Sanofi (Euronext:SAN; NASDAQ:SNY) acquired Protein Sciences...
...does not qualify as a domestically produced vaccine. Prior to Sanofi’s acquisition of the company, Protein Sciences...

...their dramatic impact has been limited to blood cancers. According to Travis Young, director of protein sciences...

...their dramatic impact has been limited to blood cancers. According to Travis Young, director of protein sciences...

...Sanofi (Euronext:SAN; NYSE:SNY) said it will acquire vaccines play Protein Sciences Corp. (Meriden, Conn.). The deal gives Sanofi...
...The deal gives Sanofi influenza vaccine Flublok Quadrivalent , which FDA approved in October 2016. Protein Sciences'...
...in total sales. Protein Sciences Corp. , Meriden, Conn. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Infectious Chris Lieu Flublok Quadrivalent Protein Sciences Corp. Sanofi...

...Sanofi (Euronext:SAN; NYSE:SNY) said it will acquire vaccines play Protein Sciences Corp. (Meriden, Conn.). The deal gives Sanofi...
...The deal gives Sanofi influenza vaccine Flublok Quadrivalent , which FDA approved in October 2016. Protein Sciences'...
...of the pharma's Sanofi Pasteur vaccines unit's €4.6 billion ($5.2 billion) in total sales. Chris Lieu Flublok Quadrivalent Protein Sciences Corp. Sanofi...

...hVIVO plc (LSE:HVO); Seek Ltd. Undisclosed vaccine Preclinical Novavax Inc. ( NASDAQ:NVAX) Undisclosed vaccine Preclinical Protein Sciences Corp....

...that target dysregulated growth factors, named Alan Buckler CSO. He was VP of cell and protein sciences...

...FDA approved an sBLA from Protein Sciences for Flublok Quadrivalent to prevent 2 influenza A subtype viruses...
...insect cells. The company markets Flublok, a trivalent formulation of the vaccine, in the U.S. Protein Sciences Corp....